⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TBPH News
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
TBPH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
accessnewswire.com
TBPH
Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Investors to Connect
accessnewswire.com
TBPH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
prnewswire.com
TBPH
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP
globenewswire.com
TBPH
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP
globenewswire.com
TBPH
Bronstein, Gewirtz & Grossman, LLC Encourages Theravance Biopharma, Inc. (TBPH) Stockholders to Inquire about Securities Investigation
accessnewswire.com
TBPH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
accessnewswire.com
TBPH
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates
prnewswire.com
TBPH
Enveda Appoints Christopher K. Porter, MBA, JD as Senior Vice President, Clinical Operations
businesswire.com
TBPH